FDA records GH¢70m surplus in 2025 amid concerns over ageing lab equipment

The Food and Drugs Authority (FDA) recorded a surplus of GH¢70 million in 2025, representing a 51 per cent increase from the GH¢46 million recorded in the previous year, despite operational challenges including ageing laboratory equipment and the circulation of illicit products.

The FDA generated total revenue of GH¢420 million during the year, made up of GH¢278 million in internally generated funds, GH¢78 million in donor support and GH¢63 million in government subsidies.

He said the FDA’s total assets rose from GH¢296 million in 2024 to GH¢358 million in 2025, while liabilities fell from GH¢12 million to GH¢3.